These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 15669363)

  • 1. [Response to drug therapy of cardiac failure according to gender].
    Juillière Y; Berder V; Brembilla-Perrot B; Selton-Suty C
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1216-20. PubMed ID: 15669363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of heart failure with preserved systolic function.
    de Groote P; Herpin D; Diévart F; Hanon O; Trochu JN; Artigou JY; Galinier M; Habib G; Juillière Y; Neuder Y; Roudaut R; Komajda M
    Arch Cardiovasc Dis; 2008 May; 101(5):361-72. PubMed ID: 18656095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Digoxin and clinical outcomes in systolic heart failure patients on contemporary background heart failure therapy.
    Dhaliwal AS; Bredikis A; Habib G; Carabello BA; Ramasubbu K; Bozkurt B
    Am J Cardiol; 2008 Nov; 102(10):1356-60. PubMed ID: 18993155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heart failure and its treatment in women. Role of hypertension, diabetes, and estrogen.
    Regitz-Zagrosek V; Lehmkuhl E
    Herz; 2005 Aug; 30(5):356-67. PubMed ID: 16132238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart failure in women.
    Pĩna IL; Buchter C
    Cardiol Rev; 2003; 11(6):337-44. PubMed ID: 14580303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug therapy of chronic heart failure in the elderly: the current state of clinical-trial evidence.
    Dulin BR; Krum H
    Curr Opin Cardiol; 2006 Jul; 21(4):393-9. PubMed ID: 16755210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observations on the management of cardiac failure in ambulatory patients. Results of a survey of cardiologists].
    Komajda M; Bouhour JB; Amouyel P; Delahaye F; Vicaut E; Croce I; Rougemond E; Vuittenez F; Leutenegger E
    Arch Mal Coeur Vaiss; 2001 Apr; 94(4):257-61. PubMed ID: 11387930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure update: treatment of heart failure with a normal left ventricular ejection fraction in the elderly.
    Aronow WS
    Geriatrics; 2006 Aug; 61(8):16-20. PubMed ID: 16901193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of heart failure by French general practitioners in 2003].
    Jondeau G; Allaert FA; Leurs I
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):833-9. PubMed ID: 15521474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ
    Ned Tijdschr Geneeskd; 1999 Jul; 143(29):1507-11. PubMed ID: 10443272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heart failure in women.
    Silber DH
    Curr Womens Health Rep; 2003 Apr; 3(2):104-9. PubMed ID: 12628079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender aspects in heart failure. Pathophysiology and medical therapy.
    Regitz-Zagrosek V; Lehmkuhl E; Lehmkuhl HB; Hetzer R
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):899-908. PubMed ID: 15521484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
    Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
    Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digoxin therapy: A persisting interest despite contrary winds.
    Juillière Y; Selton-Suty C
    Arch Cardiovasc Dis; 2010 May; 103(5):281-4. PubMed ID: 20619237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of serum digoxin concentration to mortality and morbidity in women in the digitalis investigation group trial: a retrospective analysis.
    Adams KF; Patterson JH; Gattis WA; O'Connor CM; Lee CR; Schwartz TA; Gheorghiade M
    J Am Coll Cardiol; 2005 Aug; 46(3):497-504. PubMed ID: 16053964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the outcome in men and women with chronic heart failure.
    De Feo S; Opasich C
    Ital Heart J; 2003 Aug; 4(8):511-3. PubMed ID: 14564974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Gender differences in pharmacotherapy of chronic heart failure].
    Klabník A; Murín J
    Vnitr Lek; 2009 Dec; 55(12):1167-72. PubMed ID: 20070033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.